Germany’s marijuana policies likely to remain in place under new government

Conservative and center-left parties reached an agreement Wednesday to form a new German government that leaves the country’s progressive marijuana policies intact – at least for now.

What will Germany’s election outcome mean for nation’s cannabis industry?

Conservative leader Friedrich Merz’s election victory in Germany could result in a potential slowdown or reversal of the European Union nation’s recent cannabis reform as his party has previously opposed legalization efforts.

Germany’s cannabis market is evolving, but elections loom

German voters will decide Feb. 23 between the Social Democratic Party and the Christian Democratic Union. If voters choose the CDU, cannabis reforms could slow or even be reversed.

How American cannabis cultivators can expand into Germany

With Germany’s cannabis market speedily evolving and open to international players, U.S. cultivators now have an excellent opportunity to get into a market that is already lucrative and a springboard into the rest of the European Union.

Aurora delivers its first medical cannabis crop in Germany

Canadian producer Aurora Cannabis has delivered its first flower product in Germany’s growing medical marijuana market.

Germany’s adult-use cannabis pilot programs could benefit foreign operators

Companies and scientific institutions could sell adult-use products in Germany under new legislation that allows these groups to seek licenses for cannabis pilot programs.

Tilray subsidiary launches commercial cannabis flower grown in Germany

Aphria RX, a subsidiary of Tilray Brands, launched the first commercial medical cannabis flower grown at its facility in Neumünster, Germany.

Germany’s medical cannabis sales to exceed $455M in 2024, report says

Medical cannabis sales in Germany are on pace to exceed a record 420 million euros (roughly $455.2 million) in 2024, a new report shows.

Marijuana company with Israel, Germany operations regains Nasdaq compliance

IM Cannabis Corp., a medical marijuana company operating in Israel and Germany, said it has regained compliance with the minimum-bid price requirement to list on the Nasdaq stock exchange.

Tilray branch receives medical cannabis grow license under Germany’s new law

Aphria RX, the Neumünster, Germany-based subsidiary of Tilray Brands, said Monday it received a medical marijuana cultivation license under the European country’s new Cannabis Act.

Germany approves first ‘cultivation social club’ for cannabis

Germany entered a new era for cannabis when the government of Lower Saxony, the country’s second-most-populous of 16 federal states, approved its first so-called “cultivation social club.”

Can Germany avoid overproduction as new marijuana markets ramp up?

Are the operators supplying Germany’s marijuana market today vulnerable to the same oversupply problems that Canada faced?